AtriCure traded at $40.92 this Friday June 24th, increasing $1.48 or 3.75 percent since the previous trading session. Looking back, over the last four weeks, AtriCure gained 2.76 percent. Over the last 12 months, its price fell by 48.96 percent. Looking ahead, we forecast AtriCure to be priced at 39.82 by the end of this quarter and at 36.69 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
40.92
Daily Change
3.75%
Yearly
-48.96%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 255.32 6.70 2.69% -18.05%
Abbott 109.45 3.24 3.05% -2.90%
AtriCure 40.92 1.48 3.75% -48.96%
Baxter International 66.78 1.70 2.61% -18.75%
Becton, Dickinson and Co. 250.92 8.38 3.46% 4.03%
Boston Scientific 38.02 1.08 2.92% -13.79%
Cooper Companies 323.49 15.78 5.13% -18.40%
Artivion Inc 19.39 0.26 1.36% -33.55%
Cardiovascular Systems 14.97 0.38 2.60% -66.00%
Dexcom 77.67 2.46 3.27% -81.95%
Edwards Lifesciences 96.98 3.36 3.59% -6.36%
Globus Medical 57.85 1.10 1.94% -25.32%
Integra LifeSciences 54.49 0.59 1.09% -22.20%
Inogen 26.16 -0.27 -1.02% -60.66%
Intuitive Surgical 209.67 5.17 2.53% -76.92%
J&J 182.29 2.63 1.46% 11.01%
Masimo 138.60 2.97 2.19% -43.23%
Medtronic 90.22 1.55 1.75% -27.78%
Merit Medical Systems 52.94 -0.54 -1.01% -17.86%
NuVasive 50.67 0.48 0.96% -27.50%
Insulet 227.73 8.76 4.00% -18.18%
ResMed 211.50 4.01 1.93% -13.50%
Stryker 204.43 4.37 2.18% -22.27%
Teleflex 258.05 6.56 2.61% -37.40%
Tandem Diabetes Care 61.52 2.79 4.75% -38.08%
Zimmer Biomet Holdings Inc 108.87 2.47 2.32% -34.36%

Indexes Price Day Year
USND 11608 375.43 3.34% -19.17%
US2000 1766 54.06 3.16% -24.36%

AtriCure
AtriCure, Inc. is a provider of technologies for the treatment of atrial fibrillation (Afib) and related conditions. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue, systems designed for the exclusion of the left atrial appendage, and devices designed to block pain by temporarily ablating peripheral nerves. These devices are developed and marketed to medical centers globally. Its ablation and left atrial appendage management (LAAM) products are used by physicians during both open-heart and minimally invasive procedures. Its products for open and minimally invasive ablation includes Isolator Synergy Clamp and Multifunctional Pens and Linear Ablation Devices. Its Product for open ablation are cryoICE Cryoablation System. Its product for minimally invasive ablation are EPi-Sense Guided Coagulation System with VisiTrax Technology. Its products for appendage management includes AtriClip System and LARIAT System.